BeOne Medicines (ONC) Change in Account Payables (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Change in Account Payables of -$42.2 million for Q1 2026, down 33.64% year-over-year from -$63.6 million in Q1 2025, and down 148.37% quarter-over-quarter from $87.2 million in Q4 2025.
BeOne Medicines (ONC) Change in Account Payables (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Change in Account Payables for 12 consecutive years, with -$42.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 33.64% year-over-year to -$42.2 million; the TTM figure through Mar 2026 stood at $69.2 million (up 58.64% YoY), while the FY2025 annual figure was $79.8 million, down 34.29% from the prior year.
- Change in Account Payables eased to -$42.2 million in Q1 2026 per ONC's latest filing, from $87.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $108.0 million in Q4 2024 and bottomed at -$44.1 million in Q2 2024.
- Historically, Change in Account Payables has averaged $10.4 million across 5 years, with a median of -$4.3 million in 2025.
- On a YoY basis, Change in Account Payables climbed as much as 1192.5% in 2024 and fell as far as 337.19% in 2024.
- BeOne Medicines' Change in Account Payables stood at -$8.6 million in 2022, then slipped by 15.51% to -$9.9 million in 2023, then jumped by 1192.5% to $108.0 million in 2024, then dropped by 19.22% to $87.2 million in 2025, then sank by 148.37% to -$42.2 million in 2026.
- Business Quant data shows ONC's Change in Account Payables at -$42.2 million in Q1 2026, $87.2 million in Q4 2025, and $28.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.53 Mn |
| Jun 30, 2026 | 37.53 Mn |
| Mar 31, 2026 | -42.19 Mn |
| Mar 31, 2026 | -42.19 Mn |
| Dec 31, 2025 | 87.21 Mn |
| Dec 31, 2025 | 87.21 Mn |
| Sep 30, 2025 | 28.47 Mn |
| Sep 30, 2025 | 28.47 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Mar 31, 2025 | -31.57 Mn |
| Mar 31, 2025 | -31.57 Mn |
| Dec 31, 2024 | 107.96 Mn |
| Dec 31, 2024 | 107.96 Mn |
| Sep 30, 2024 | 11.34 Mn |
| Sep 30, 2024 | 11.34 Mn |
| Jun 30, 2024 | -44.11 Mn |
| Jun 30, 2024 | -44.11 Mn |
| Mar 31, 2024 | 46.30 Mn |
| Mar 31, 2024 | 46.30 Mn |